Issues related to waiver of intellectual property rights for COVID therapeutics and diagnostics. International trade and protection of intellectual property, HIV policy issue, Hepatitis C (HCV) policy issues, the CREATES Act (S.3506); PEPFAR; public health initiatives around opioids and infectious diseases.; Issues related to waiver of intellectual property rights for COVID therapeutics and diagnostics. International trade and protection of intellectual property, HIV policy issue, Hepatitis C (HCV) policy issues, the CREATES Act (S.3506); PEPFAR; public health initiatives around opioids and infectious diseases.; general healthcare issues.
CPT - Copyright/Patent/Trademark TRD - Trade (domestic/foreign) HCR - Health Issues
16 - Natl Security Council (NSC) 1 - SENATE 22 - U.S. Trade Representative (USTR) 24 - Commerce, Dept of (DOC) 16 - Natl Security Council (NSC) 1 - SENATE 22 - U.S. Trade Representative (USTR) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AKIN GUMP STRAUSS HAUER & FELD
2001 K St NW, WASHINGTON, DC, 20006, US
BRIAN ARTHUR POMPER STEPHEN KHO BRIAN ARTHUR POMPER STEPHEN KHO VIRGIL MILLER LOUIS AGNELLO